DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

SECC Scottish Exhibition and Conference Centre

2017 年 03 月 29 日 9:00 上午 - 2017 年 03 月 29 日 12:30 下午

Exhibition Way, Glasgow, G3 8YW, United Kingdom

SC03: Introduction to the Regulation of Medical Devices and Medical Software

概览

This tutorial will give a condensed overview of the EU device legislative system and the principles and philosophy supporting them. It will also explain the definition of a medical device, the delineation between medical devices and pharmaceuticals and the provisions on combination products. Legal provisions for medical software, regulated as a medical device will be highlighted. The characteristics and the organisational structure of the medical device sector and the role of the various stakeholders will be discussed as well as the concept of risk classification of medical devices and the relationship between risk classification and conformity assessment procedures.

The tutorial will also cover the headlines of the EU regulation of in vitro diagnostics, with a focus on the differences to the medical device regulation. Theoretical concepts will be illustrated and supported by practical examples.

Finally, we will look ahead into the main changes resulting from the ongoing revision of the medical device and in vitro diagnostic regulations.

谁应该参加?

Professionals in the pharmaceutical or medical device area (e.g. regulatory affairs, clinical development), who are:

  • Interested in a condensed overview of the EU medical device regulatory system
  • Involved in the development and marketing of drug device combinations
  • Interested in medical software regulation

学习目标

  • Understand the main characteristics of the EU medical devices regulatory system, how it operates and how to bring a medical device to market
  • Understand the delineation between pharmaceutical and medical devices
  • Learn about the regulation of medical software and medical apps
  • Discover the main changes resulting from the currently ongoing legislative review process

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。